View Products

Search Products

Order Form

Rejuvenation Medicine

FAQs

Health Concerns

Contact Us

Who We Are

Home

Kava-Kava
Relaxocomp
St john’s Wort Plus
Magnesium Glycinate

Kava-Kava Extract WS 1490 versus Placebo in Anxiety Disorders - A RandomizedPlacebo-controlled 25-week Outpatient Trial
Author(s): Volz HP, Kieser M Source: Pharmacopsychiat. 1997; 30:1-5.
Abstract:
101 outpatients suffering from anxiety of non-psychotic origin (DSM-111-R criteria: agoraphobia, specific phobia, generalized anxiety disorder, and adjustment disorder with anxiety) were included in a 25-week multicenter randomized placebo-controlled double-blind trial with WS 1490, a special extract of kava-kava. In the main outcome criterion, the Hamilton Anxiety Scale
(HAMA), there was a significant superiority of the test drug starting from week 8 on. WS 1490 was also found to be superior
with respect to the secondary outcome variables. HAMA subscores somatic and psychic anxiety, Clinical Global Impression,
Self-Report Symptom Inventory - 90 Items revised, and Adjective Mood Scale. Adverse events were rare and distributed evenly in both groups. These results support WS 1490 as a treatment alternative to tricyclic antidepressants and benzodiazepines in anxiety disorders, with proven long-term efficacy and none of the tolerance problems associated with tricyclics and benzodiazepines.

Magnesium Glycinate
For mild anxiety, magnesium may be relaxing. Typically, 200–300 mg of magnesium are taken two to three times per day. Soaking in a hot tub containing 1–2 cups of magnesium sulfate crystals (such as Epsom salts) for fifteen to twenty minutes.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.